ProCE Banner Activity

Current Challenges in the Management of Endometrial and Ovarian Cancers

Conference Coverage
Clinical Thought

How do you currently address management challenges in patients with endometrial and ovarian cancers? Read our thoughts on how we currently approach challenges with novel therapies for the treatment of endometrial and ovarian cancers.

This ClinicalThought is intended for clinicians practicing medicine outside of the United States.

Released: May 03, 2021

Expiration: May 02, 2022

No longer available for credit.

Share

Faculty

Jubilee Brown

Jubilee Brown, MD

Professor and Division Director
Gynecologic Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Ursula Matulonis

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology
Brock-Wilson Faculty Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Supporters

This educational activity is supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Jubilee Brown, MD

Professor and Division Director
Gynecologic Oncology
Levine Cancer Institute, Atrium Health
Charlotte, North Carolina

Jubilee Brown, MD, has disclosed that she has received funds for research support from GlaxoSmithKline, Olympus, and Tesaro.

Ursula Matulonis, MD

Chief, Division of Gynecologic Oncology
Brock-Wilson Faculty Chair
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Ursula Matulonis, MD, has disclosed that she has received consulting fees from GlaxoSmithKline, Merck, NextCure, and Novartis.